Hybrid approach to structure modeling of the histamine H3 receptor: Multi-level assessment as a tool for model verification

The crucial role of G-protein coupled receptors and the significant achievements associated with a better understanding of the spatial structure of known receptors in this family encouraged us to undertake a study on the histamine H3 receptor, whose crystal structure is still unresolved. The latest literature data and availability of different software enabled us to build homology models of higher accuracy than previously published ones. The new models are expected to be closer to crystal structures; and therefore, they are much more helpful in the design of potential ligands. In this article, we describe the generation of homology models with the use of diverse tools and a hybrid assessment. Our study incorporates a hybrid assessment connecting knowledge-based scoring algorithms with a two-step ligand-based docking procedure. Knowledge-based scoring employs probability theory for global energy minimum determination based on information about native amino acid conformation from a dataset of experimentally determined protein structures. For a two-step docking procedure two programs were applied: GOLD was used in the first step and Glide in the second. Hybrid approaches offer advantages by combining various theoretical methods in one modeling algorithm. The biggest advantage of hybrid methods is their intrinsic ability to self-update and self-refine when additional structural data are acquired. Moreover, the diversity of computational methods and structural data used in hybrid approaches for structure prediction limit inaccuracies resulting from theoretical approximations or fuzziness of experimental data. The results of docking to the new H3 receptor model allowed us to analyze ligand—receptor interactions for reference compounds.

[1]  A. Sugawara,et al.  The expression and function of histamine H3 receptors in pancreatic beta cells , 2014, British journal of pharmacology.

[2]  J. Brioni,et al.  In-vivo histamine H3 receptor antagonism activates cellular signaling suggestive of symptomatic and disease modifying efficacy in Alzheimer’s disease , 2011, Neuropharmacology.

[3]  Yang Zhang,et al.  The I-TASSER Suite: protein structure and function prediction , 2014, Nature Methods.

[4]  Manfred Burghammer,et al.  Structure of bovine rhodopsin in a trigonal crystal form. , 2003, Journal of molecular biology.

[5]  B. Trzaskowski,et al.  Action of Molecular Switches in GPCRs - Theoretical and Experimental Studies , 2012, Current medicinal chemistry.

[6]  J. Schwartz,et al.  Determination of the binding mode and interacting amino-acids for dibasic H3 receptor antagonists. , 2013, Bioorganic & medicinal chemistry.

[7]  R. Leurs,et al.  The Akt/GSK‐3β axis as a new signaling pathway of the histamine H3 receptor , 2007 .

[8]  John Dunlop,et al.  The role of transmembrane helix 5 in agonist binding to the human H3 receptor. , 2002, The Journal of pharmacology and experimental therapeutics.

[9]  Ricardo Márquez-Gómez,et al.  Histamine H3 receptor activation counteracts adenosine A2A receptor-mediated enhancement of depolarization-evoked [3H]-GABA release from rat globus pallidus synaptosomes. , 2014, ACS chemical neuroscience.

[10]  H. Haas,et al.  Histamine in the nervous system. , 2008, Physiological reviews.

[11]  A. J. Venkatakrishnan,et al.  Diverse activation pathways in class A GPCRs converge near the G-protein-coupling region , 2016, Nature.

[12]  P. Blandina,et al.  Central histaminergic system and cognition , 2000, Neuroscience & Biobehavioral Reviews.

[13]  E. Levin,et al.  JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in rats , 2011, Psychopharmacology.

[14]  Saskia Nijmeijer,et al.  Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies. , 2011, Journal of medicinal chemistry.

[15]  J. Klco,et al.  Essential role for the second extracellular loop in C5a receptor activation , 2005, Nature Structural &Molecular Biology.

[16]  Rob Leurs,et al.  Delineation of Receptor‐Ligand Interactions at the Human Histamine H1 Receptor by a Combined Approach of Site‐Directed Mutagenesis and Computational Techniques – or – How to Bind the H1 Receptor , 2005, Archiv der Pharmazie.

[17]  N. Oudart,et al.  Bronchodilatation of guinea‐pig perfused bronchioles induced by the H3‐receptor for histamine: role of epithelium , 1993, British journal of pharmacology.

[18]  J. Wess,et al.  Multiple Residues in the Second Extracellular Loop Are Critical for M3 Muscarinic Acetylcholine Receptor Activation* , 2007, Journal of Biological Chemistry.

[19]  A. Elofsson,et al.  Multi-domain proteins in the three kingdoms of life: orphan domains and other unassigned regions. , 2005, Journal of molecular biology.

[20]  J. Ballesteros,et al.  G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin. , 2001, Current opinion in drug discovery & development.

[21]  A. Buschauer,et al.  The Extracellular Loop 2 (ECL2) of the Human Histamine H4 Receptor Substantially Contributes to Ligand Binding and Constitutive Activity , 2015, PloS one.

[22]  A. Hancock,et al.  Molecular modeling and pharmacological analysis of species-related histamine H3 receptor heterogeneity , 2003, Neuropharmacology.

[23]  Saskia Nijmeijer,et al.  Mapping histamine H4 receptor–ligand binding modes , 2013 .

[24]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[25]  H. Stark,et al.  Chlorophenoxy aminoalkyl derivatives as histamine H(3)R ligands and antiseizure agents. , 2016, Bioorganic & medicinal chemistry.

[26]  P Kolb,et al.  GPCRdb: the G protein‐coupled receptor database – an introduction , 2016, British journal of pharmacology.

[27]  Robert P Bywater,et al.  Location and nature of the residues important for ligand recognition in G‐protein coupled receptors , 2005, Journal of molecular recognition : JMR.

[28]  J. Emmerich,et al.  The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use. , 2017, Sleep medicine.

[29]  Scott D Bembenek,et al.  Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore. , 2006, Journal of molecular graphics & modelling.

[30]  Sylvain Crochet,et al.  The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders. , 2004, Trends in pharmacological sciences.

[31]  Martin J. Lohse,et al.  Mutations of Tyr326 in the β2-adrenoceptor disrupt multiple receptor functions , 1996 .

[32]  G. V. van Westen,et al.  Importance of the extracellular loops in G protein-coupled receptors for ligand recognition and receptor activation. , 2011, Trends in pharmacological sciences.

[33]  Stephen M. Husbands,et al.  Structural insights into μ-opioid receptor activation , 2015, Nature.

[34]  Lei Xie,et al.  Using multiple structure alignments, fast model building, and energetic analysis in fold recognition and homology modeling , 2003, Proteins.

[35]  Pascal Benkert,et al.  QMEAN server for protein model quality estimation , 2009, Nucleic Acids Res..

[36]  Francesca Fanelli,et al.  Mutagenesis and modelling of the alpha(1b)-adrenergic receptor highlight the role of the helix 3/helix 6 interface in receptor activation. , 2002, Molecular pharmacology.

[37]  H. Kotani,et al.  Enhanced Histaminergic Neurotransmission and Sleep-Wake Alterations, a Study in Histamine H3-Receptor Knock-Out Mice , 2013, Neuropsychopharmacology.

[38]  Holger Stark,et al.  Histamine H3 receptor antagonists go to clinics. , 2008, Biological & pharmaceutical bulletin.

[39]  Zhexin Xiang,et al.  Homology-Based Modeling of Protein Structure , 2007 .

[40]  Hiroki Yoneyama,et al.  Synthesis and evaluation of N-alkyl-S-[3-(piperidin-1-yl)propyl]isothioureas: high affinity and human/rat species-selective histamine H(3) receptor antagonists. , 2013, Bioorganic & medicinal chemistry letters.

[41]  Claudio N. Cavasotto,et al.  Ligand and Decoy Sets for Docking to G Protein-Coupled Receptors , 2012, J. Chem. Inf. Model..

[42]  Ruben Abagyan,et al.  Structure of the human histamine H1 receptor complex with doxepin , 2011, Nature.

[43]  A. Strasser,et al.  Role of the second and third extracellular loops of the histamine H4 receptor in receptor activation , 2011, Naunyn-Schmiedeberg's Archives of Pharmacology.

[44]  K. Currie,et al.  Regulation of Ca(V)2 calcium channels by G protein coupled receptors. , 2013, Biochimica et biophysica acta.

[45]  Thorsten Meinl,et al.  KNIME: The Konstanz Information Miner , 2007, GfKl.

[46]  D. Higgins,et al.  Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega , 2011, Molecular systems biology.

[47]  J. Schwartz,et al.  Highly potent and selective ligands for histamine H3-receptors , 1987, Nature.

[48]  Dorota Latek,et al.  A Hybrid Approach to Structure and Function Modeling of G Protein-Coupled Receptors , 2016, J. Chem. Inf. Model..

[49]  K. Kieć‐Kononowicz,et al.  New developments around histamine H3 receptor antagonists/inverse agonists: a patent review (2010 – present) , 2014, Expert opinion on therapeutic patents.

[50]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[51]  Min Zhang,et al.  Pharmacological Properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist , 2005, Journal of Pharmacology and Experimental Therapeutics.

[52]  Gaetano T Montelione,et al.  Evaluating protein structures determined by structural genomics consortia , 2006, Proteins.

[53]  C. Rizzo,et al.  Coordination of Histamine H3 Receptor Antagonists with Human Adrenal Cytochrome P450 Enzymes , 2002, Pharmacology.

[54]  C. Humblet,et al.  Modeling G protein‐coupled receptors for structure‐based drug discovery using low‐frequency normal modes for refinement of homology models: Application to H3 antagonists , 2010, Proteins.

[55]  Xavier Deupi,et al.  Structural insights into agonist-induced activation of G-protein-coupled receptors. , 2011, Current opinion in structural biology.

[56]  H. Stark,et al.  Refined Docking as a Valuable Tool for Lead Optimization: Application to Histamine H3 Receptor Antagonists , 2008, Archiv der Pharmazie.

[57]  Kurt Kristiansen,et al.  Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. , 2004, Pharmacology & therapeutics.

[58]  William A. Goddard,et al.  Structure-Based Prediction of Subtype Selectivity of Histamine H3 Receptor Selective Antagonists in Clinical Trials , 2011, J. Chem. Inf. Model..

[59]  G. Abbott,et al.  Cardioprotective Effect of Histamine H3-Receptor Activation: Pivotal Role of Gβγ-Dependent Inhibition of Voltage-Operated Ca2+ Channels , 2008, Journal of Pharmacology and Experimental Therapeutics.

[60]  Torsten Schwede,et al.  BIOINFORMATICS Bioinformatics Advance Access published November 12, 2005 The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling , 2022 .

[61]  H P Rang,et al.  Rang and Dale's pharmacology , 2012 .

[62]  The Uniprot Consortium,et al.  UniProt: a hub for protein information , 2014, Nucleic Acids Res..

[63]  J. Schwartz,et al.  Efficacy of the histamine 3 receptor (H3R) antagonist pitolisant (formerly known as tiprolisant; BF2.649) in epilepsy: Dose-dependent effects in the human photosensitivity model , 2013, Epilepsy & Behavior.

[64]  J. Schwartz,et al.  Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor , 1983, Nature.

[65]  H. Timmerman,et al.  Isothiourea analogues of histamine as potent agonists or antagonists of the histamine H3-receptor , 1992 .

[66]  María Martín,et al.  UniProt: A hub for protein information , 2015 .

[67]  R. Leurs,et al.  Molecular aspects of the histamine H3 receptor. , 2007, Biochemical pharmacology.

[68]  Gerhard Klebe,et al.  DSX: A Knowledge-Based Scoring Function for the Assessment of Protein-Ligand Complexes , 2011, J. Chem. Inf. Model..

[69]  Yongchao Liu,et al.  MSAProbs-MPI: parallel multiple sequence aligner for distributed-memory systems , 2016, Bioinform..

[70]  Jakub Jończyk,et al.  Therapeutic strategies for Alzheimer’s disease in clinical trials , 2016, Pharmacological reports : PR.

[71]  M. Jackson,et al.  Cloning and functional expression of the human histamine H3 receptor. , 1999, Molecular pharmacology.

[72]  P. Maruff,et al.  A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's disease. , 2014, Current Alzheimer Research.

[73]  M. Fidock,et al.  Maximizing serendipity: strategies for identifying ligands for orphan G-protein-coupled receptors. , 2003, Current opinion in pharmacology.

[74]  James M Aramini,et al.  Assessment of template‐based protein structure predictions in CASP10 , 2014, Proteins.

[75]  Ben M. Webb,et al.  Comparative Protein Structure Modeling Using MODELLER , 2016, Current protocols in bioinformatics.

[76]  M. Williams,et al.  Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist. , 2004, Biochemical pharmacology.

[77]  A. Hancock H3 receptor antagonists/inverse agonists as anti-obesity agents. , 2003, Current opinion in investigational drugs.

[78]  Holger Stark,et al.  High constitutive activity of native H3 receptors regulates histamine neurons in brain , 2000, Nature.

[79]  J. Meiler,et al.  BCL::Score—Knowledge Based Energy Potentials for Ranking Protein Models Represented by Idealized Secondary Structure Elements , 2012, PloS one.

[80]  Roland L Dunbrack,et al.  Assessment of template‐based modeling of protein structure in CASP11 , 2016, Proteins.

[81]  Richard D. Taylor,et al.  Improved protein–ligand docking using GOLD , 2003, Proteins.

[82]  Gerhard Klebe,et al.  Comparison of Automatic Three-Dimensional Model Builders Using 639 X-ray Structures , 1994, J. Chem. Inf. Comput. Sci..